FAST NEWS: Fosun Pharma Raises $660 Million in Non-public Placement of A-Shares
The latest: Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (2196.HK; 600196.SH) announced on Wednesday it plans to raise up to 4.48 billion yuan ($660 million) through a non-public offering of about…
RELATED ARTICLES
-
Fosun moves on from debt crisis with renewed focus on tourism, healthcare
0656.HK -
Fosun Tourism travels back to home base with delisting plan
1992.HK 0656.HK
-
BRIEF: Fosun pledges 27% of Fosun Pharma’s A-shares
2196.HK 600196.SHG
-
After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
2696.HK
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK
-
Country Garden’s debt restructure hinges on stabilizing property market
2007.HK
